Eto Y - Search Results

1

Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease.

Yokoi T, Kobayashi H, Shimada Y, Eto Y, Ishige N, Kitagawa T, Otsu M, Nakauchi H, Ida H, Ohashi T. Yokoi T, et al. Among authors: eto y. J Gene Med. 2011 May;13(5):262-8. doi: 10.1002/jgm.1566. J Gene Med. 2011. PMID: 21520359

2

Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease.

Shen JS, Meng XL, Maeda H, Ohashi T, Eto Y. Shen JS, et al. Among authors: eto y. J Gene Med. 2004 Nov;6(11):1206-15. doi: 10.1002/jgm.630. J Gene Med. 2004. PMID: 15459963

3

Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy.

Ohashi T, Sakuma M, Kitagawa T, Suzuki K, Ishige N, Eto Y. Ohashi T, et al. Among authors: eto y. Mol Genet Metab. 2007 Nov;92(3):271-3. doi: 10.1016/j.ymgme.2007.06.013. Epub 2007 Aug 8. Mol Genet Metab. 2007. PMID: 17689998

4

Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.

Ohashi T, Iizuka S, Ida H, Eto Y. Ohashi T, et al. Among authors: eto y. Mol Genet Metab. 2008 Jul;94(3):313-8. doi: 10.1016/j.ymgme.2008.03.008. Epub 2008 May 5. Mol Genet Metab. 2008. PMID: 18456533

5

Administration of anti-CD3 antibodies modulates the immune response to an infusion of α-glucosidase in mice.

Ohashi T, Iizuka S, Shimada Y, Higuchi T, Eto Y, Ida H, Kobayashi H. Ohashi T, et al. Among authors: eto y. Mol Ther. 2012 Oct;20(10):1924-31. doi: 10.1038/mt.2012.133. Epub 2012 Aug 7. Mol Ther. 2012. PMID: 22871665 Free PMC article.

6

Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice.

Akiyama K, Shimada Y, Higuchi T, Ohtsu M, Nakauchi H, Kobayashi H, Fukuda T, Ida H, Eto Y, Crawford BE, Brown JR, Ohashi T. Akiyama K, et al. Among authors: eto y. Mol Genet Metab. 2014 Feb;111(2):139-46. doi: 10.1016/j.ymgme.2013.09.013. Epub 2013 Sep 21. Mol Genet Metab. 2014. PMID: 24100247

7

Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II.

Wakabayashi T, Shimada Y, Akiyama K, Higuchi T, Fukuda T, Kobayashi H, Eto Y, Ida H, Ohashi T. Wakabayashi T, et al. Among authors: eto y. Hum Gene Ther. 2015 Jun;26(6):357-66. doi: 10.1089/hum.2014.158. Epub 2015 Apr 20. Hum Gene Ther. 2015. PMID: 25761450

8

Novel treatment for neuronopathic lysosomal storage diseases--cell therapy/gene therapy.

Eto Y, Ohashi T. Eto Y, et al. Curr Mol Med. 2002 Feb;2(1):83-9. doi: 10.2174/1566524023363112. Curr Mol Med. 2002. PMID: 11898850 Review.

9

Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease.

Shen JS, Meng XL, Yokoo T, Sakurai K, Watabe K, Ohashi T, Eto Y. Shen JS, et al. Among authors: eto y. J Gene Med. 2005 May;7(5):540-51. doi: 10.1002/jgm.719. J Gene Med. 2005. PMID: 15685691

10

Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry.

Kitagawa T, Ishige N, Suzuki K, Owada M, Ohashi T, Kobayashi M, Eto Y, Tanaka A, Mills K, Winchester B, Keutzer J. Kitagawa T, et al. Among authors: eto y. Mol Genet Metab. 2005 Jul;85(3):196-202. doi: 10.1016/j.ymgme.2005.01.007. Epub 2005 Apr 26. Mol Genet Metab. 2005. PMID: 15979031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters